Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-31 Sale | 2023-11-01 4:41 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,080 | $5.1974 | $5,613 | 132,352 (Direct) | View |
| 2023-10-31 Sale | 2023-11-01 4:40 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,232 | $5.1974 | $6,403 | 52,580 (Direct) | View |
| 2023-10-31 Sale | 2023-11-01 4:40 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,633 | $5.1974 | $8,487 | 82,390 (Direct) | View |
| 2023-07-31 Sale | 2023-08-01 4:28 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,245 | $9.6547 | $12,020 | 133,432 (Direct) | View |
| 2023-07-31 Sale | 2023-08-01 4:27 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 1,420 | $9.6547 | $13,710 | 53,785 (Direct) | View |
| 2023-07-31 Sale | 2023-08-01 4:26 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,884 | $9.6547 | $18,189 | 84,023 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 4:33 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 342 | $9.8763 | $3,378 | 16,695 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 4:33 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 721 | $9.8763 | $7,121 | 110,677 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 4:32 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 682 | $9.8763 | $6,736 | 31,205 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 4:31 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,136 | $9.8763 | $11,219 | 61,907 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:18 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 424 | $11.78 | $4,995 | 15,484 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:17 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 924 | $11.78 | $10,884 | 111,398 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:16 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 848 | $11.78 | $9,989 | 30,350 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:15 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,412 | $11.78 | $16,633 | 61,490 (Direct) | View |
| 2022-10-31 Sale | 2022-11-01 7:35 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 739 | $12.88 | $9,519 | 112,322 (Direct) | View |
| 2022-10-31 Sale | 2022-11-01 7:34 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 699 | $12.88 | $9,003 | 31,198 (Direct) | View |
| 2022-10-31 Sale | 2022-11-01 7:33 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,165 | $12.88 | $15,006 | 62,902 (Direct) | View |
| 2022-10-31 Sale | 2022-11-01 7:32 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 350 | $12.88 | $4,508 | 15,908 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 5:50 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 712 | $15.67 | $11,157 | 31,552 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 5:48 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 356 | $15.67 | $5,579 | 14,706 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 5:46 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 752 | $15.67 | $11,784 | 113,061 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 5:45 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,186 | $15.67 | $18,585 | 64,067 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-30 Exercise | 2023-11-01 4:41 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,886 | $0 | 132,352 (Direct) | View |
| 2023-10-30 Exercise | 2023-11-01 4:40 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,924 | $0 | 52,580 (Direct) | View |
| 2023-10-30 Exercise | 2023-11-01 4:40 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 5,207 | $0 | 82,390 (Direct) | View |
| 2023-07-30 Exercise | 2023-08-01 4:28 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,886 | $0 | 133,432 (Direct) | View |
| 2023-07-30 Exercise | 2023-08-01 4:27 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 3,924 | $0 | 53,785 (Direct) | View |
| 2023-07-30 Exercise | 2023-08-01 4:26 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 5,207 | $0 | 84,023 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 8:00 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 7:58 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 7:58 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 7:57 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 7:56 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 7:55 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-04-30 Exercise | 2023-05-02 4:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 16,695 (Direct) | View |
| 2023-04-30 Exercise | 2023-05-02 4:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 110,677 (Direct) | View |
| 2023-04-30 Exercise | 2023-05-02 4:32 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 1,924 | $0 | 31,205 (Direct) | View |
| 2023-04-30 Exercise | 2023-05-02 4:31 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,206 | $0 | 61,907 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-15 4:14 pm | N/A 2033-02-13 | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 112,900 | $0 | 112,900 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-15 4:13 pm | N/A 2033-02-13 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 112,900 | $0 | 112,900 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-15 4:12 pm | N/A 2033-02-13 | Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO | 448,000 | $0 | 448,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-15 4:11 pm | N/A 2033-02-13 | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 112,900 | $0 | 112,900 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-15 4:10 pm | N/A 2033-02-13 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 112,900 | $0 | 112,900 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:18 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 15,484 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:17 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 111,398 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:16 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 1,924 | $0 | 30,350 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:15 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,207 | $0 | 61,490 (Direct) | View |
| 2022-10-30 Exercise | 2022-11-01 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 112,322 (Direct) | View |
| 2022-10-30 Exercise | 2022-11-01 7:34 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 1,924 | $0 | 31,198 (Direct) | View |
| 2022-10-30 Exercise | 2022-11-01 7:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,207 | $0 | 62,902 (Direct) | View |
| 2022-10-30 Exercise | 2022-11-01 7:32 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 15,908 (Direct) | View |
| 2022-09-12 Option Award | 2022-09-14 4:25 pm | N/A 2032-09-11 | Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-10 4:19 pm | N/A 2032-08-08 | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 40,199 | $0 | 40,199 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-10 4:18 pm | N/A 2032-08-08 | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 110,375 | $0 | 110,375 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-10 4:17 pm | N/A 2032-08-08 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-10 4:16 pm | N/A 2032-08-08 | Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-10 4:15 pm | N/A 2032-08-08 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 60,298 | $0 | 60,298 (Direct) | View |
| 2022-07-30 Exercise | 2022-08-02 5:50 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel | 1,924 | $0 | 31,552 (Direct) | View |
| 2022-07-30 Exercise | 2022-08-02 5:48 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 14,706 (Direct) | View |
| 2022-07-30 Exercise | 2022-08-02 5:46 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,886 | $0 | 113,061 (Direct) | View |
| 2022-07-30 Exercise | 2022-08-02 5:45 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,207 | $0 | 64,067 (Direct) | View |